Klinique Medical Clinic Public Co. Ltd.(TH:KLINIQ)
฿33.75+0.75 (+2.27%)
TH:KLINIQ
Klinique Medical Clinic Public Co. Ltd. financials statements
฿33.75
At close:+0.75 (+2.27%)
Klinique Medical Clinic Public Co. Ltd. (KLINIQ) Ratios
Klinique Medical Clinic Public Co. Ltd. Ratios
TH:KLINIQ's free cash flow for Q2 2026 was ฿85.43M. For the 2026 fiscal year, TH:KLINIQ's free cash flow was decreased by ฿-48.24M and operating cash flow was ฿133.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.17 | 1.32 | 1.93 | 2.38 | 0.41 |
| Quick Ratio | 0.80 | 1.01 | 1.68 | 2.21 | 0.24 |
| Cash Ratio | 0.31 | 0.29 | 0.14 | 0.66 | 0.15 |
| Solvency Ratio | 0.41 | 0.43 | 0.42 | 0.37 | 0.32 |
| Operating Cash Flow Ratio | 0.66 | 0.64 | 0.50 | 0.58 | 0.48 |
| Short-Term Operating Cash Flow Coverage | 4.13 | 3.79 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ฿ -498.74M | ฿ -257.01M | ฿ 334.47M | ฿ 733.07M | ฿ -461.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.26 | 0.16 | 0.12 | 0.25 |
| Debt-to-Equity Ratio | 0.69 | 0.47 | 0.27 | 0.19 | 1.29 |
| Debt-to-Capital Ratio | 0.41 | 0.32 | 0.21 | 0.16 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.96 | 1.82 | 1.67 | 1.57 | 5.14 |
| Debt Service Coverage Ratio | 3.68 | 3.71 | 32.99 | 33.49 | 49.74 |
| Interest Coverage Ratio | 17.61 | 16.67 | 22.85 | 23.99 | 35.50 |
| Debt to Market Cap | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.68 | 3.76 | 2.17 | 1.44 | 0.96 |
| Net Debt to EBITDA | 1.15 | 0.80 | 0.63 | -0.40 | 0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.51% | 51.71% | 54.05% | 56.31% | 58.82% |
| EBIT Margin | 13.04% | 13.91% | 15.99% | 15.60% | 16.13% |
| EBITDA Margin | 22.25% | 23.37% | 24.50% | 24.27% | 24.68% |
| Operating Profit Margin | 13.04% | 13.36% | 15.11% | 15.60% | 16.13% |
| Pretax Profit Margin | 12.96% | 13.10% | 15.33% | 15.02% | 15.68% |
| Net Profit Margin | 10.23% | 10.80% | 12.63% | 12.54% | 13.61% |
| Continuous Operations Profit Margin | 10.24% | 10.80% | 12.63% | 12.54% | 13.61% |
| Net Income Per EBT | 78.88% | 82.42% | 82.41% | 83.47% | 86.76% |
| EBT Per EBIT | 99.41% | 98.08% | 101.47% | 96.27% | 97.22% |
| Return on Assets (ROA) | 10.46% | 10.33% | 10.14% | 7.93% | 15.67% |
| Return on Equity (ROE) | 20.51% | 18.77% | 16.95% | 12.49% | 80.53% |
| Return on Capital Employed (ROCE) | 18.87% | 17.69% | 16.60% | 13.57% | 47.04% |
| Return on Invested Capital (ROIC) | 13.23% | 13.00% | 13.11% | 10.91% | 34.63% |
| Return on Tangible Assets | 10.47% | 10.35% | 10.16% | 7.94% | 15.72% |
| Earnings Yield | 7.73% | 4.51% | 3.07% | 2.41% | 2.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 278.27 | 61.51 | 183.71 | 31.11 | 27.04 |
| Payables Turnover | 11.58 | 12.27 | 11.83 | 11.39 | 11.93 |
| Inventory Turnover | 4.58 | 5.30 | 5.49 | 5.96 | 4.64 |
| Fixed Asset Turnover | 1.89 | 1.66 | 1.88 | 2.00 | 1.78 |
| Asset Turnover | 1.02 | 0.96 | 0.80 | 0.63 | 1.15 |
| Working Capital Turnover Ratio | 15.58 | 6.02 | 2.71 | 4.85 | -3.18 |
| Cash Conversion Cycle | 49.53 | 45.02 | 37.55 | 40.88 | 61.51 |
| Days of Sales Outstanding | 1.31 | 5.93 | 1.99 | 11.73 | 13.50 |
| Days of Inventory Outstanding | 79.75 | 68.83 | 66.43 | 61.19 | 78.60 |
| Days of Payables Outstanding | 31.53 | 29.74 | 30.87 | 32.05 | 30.59 |
| Operating Cycle | 81.06 | 74.76 | 68.42 | 72.93 | 92.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.05 | 2.51 | 1.75 | 1.85 | 1.08 |
| Free Cash Flow Per Share | 1.69 | -0.09 | 0.09 | 0.82 | 0.75 |
| Dividend Paid and CapEx Coverage Ratio | 1.08 | 0.63 | 0.65 | 1.07 | 1.55 |
| Capital Expenditure Coverage Ratio | 2.24 | 0.96 | 1.05 | 1.80 | 3.22 |
| Operating Cash Flow Coverage Ratio | 0.55 | 0.69 | 0.84 | 1.34 | 1.15 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.19 | 0.17 | 0.25 | 0.25 |
| Free Cash Flow Yield | 7.89% | -0.29% | 0.20% | 2.12% | 3.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.97 | 22.26 | 32.63 | 41.67 | 41.53 |
| Price-to-Sales (P/S) Ratio | 1.32 | 2.40 | 4.12 | 5.20 | 5.67 |
| Price-to-Book (P/B) Ratio | 2.65 | 4.16 | 5.52 | 5.18 | 33.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.68 | -343.22 | 500.10 | 47.10 | 32.76 |
| Price-to-Operating Cash Flow Ratio | 7.01 | 12.95 | 24.37 | 20.90 | 22.59 |
| Price-to-Earnings Growth (PEG) Ratio | 1.00 | 1.94 | 0.80 | 0.72 | -3.92 |
| Enterprise Value Multiple | 7.10 | 11.05 | 17.43 | 21.03 | 23.55 |
| Enterprise Value | 5.62B | 7.71B | 9.76B | 8.37B | 5.52B |
| EV to EBITDA | 7.10 | 11.05 | 17.43 | 21.03 | 23.55 |
| EV to Sales | 1.58 | 2.58 | 4.27 | 5.10 | 5.81 |
| EV to Free Cash Flow | 15.12 | -369.89 | 518.87 | 46.22 | 33.56 |
| EV to Operating Cash Flow | 8.36 | 13.96 | 25.29 | 20.51 | 23.14 |
| Tangible Book Value Per Share | 8.08 | 7.78 | 7.72 | 7.46 | 0.72 |
| Shareholders’ Equity Per Share | 8.06 | 7.80 | 7.74 | 7.48 | 0.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.18 | 0.18 | 0.17 | 0.13 |
| Revenue Per Share | 16.17 | 13.56 | 10.39 | 7.45 | 4.32 |
| Net Income Per Share | 1.65 | 1.46 | 1.31 | 0.93 | 0.59 |
| Tax Burden | 0.79 | 0.82 | 0.82 | 0.83 | 0.87 |
| Interest Burden | 0.99 | 0.94 | 0.96 | 0.96 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.37 | 0.39 | 0.40 | 0.41 | 0.43 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.85 | 1.71 | 1.34 | 1.99 | 1.85 |
Currency in THB
